The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2022
DOI: 10.1007/s12247-022-09625-1
|View full text |Cite
|
Sign up to set email alerts
|

Preparation and Evaluation of Extended-Release Nanofibers Loaded with Pramipexole as a Novel Oral Drug Delivery System: Hybridization of Hydrophilic and Hydrophobic Polymers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 32 publications
0
1
0
Order By: Relevance
“…Limoee et al reported that the release rate of Pramipexole from hybrid crosslinked nanofibers was successfully controlled between 8 and 10 h, which is approximately the same time that the drug formulation travels from the mouth to the small intestine. It is worthwhile mentioning that the hybrid cross-linked nanofibers in this work were made of a mixture of a hydrophilic polymeric matrix (polyvinyl alcohol and carboxymethyl cellulose) and a hydrophobic polymer (polycaprolactone) [16]. Interestingly, the nature of the drug and the drug-polymer compatibility strongly affect the release behavior of the drug from nanofiber scaffolds [14,[17][18][19].…”
Section: Introductionmentioning
confidence: 99%
“…Limoee et al reported that the release rate of Pramipexole from hybrid crosslinked nanofibers was successfully controlled between 8 and 10 h, which is approximately the same time that the drug formulation travels from the mouth to the small intestine. It is worthwhile mentioning that the hybrid cross-linked nanofibers in this work were made of a mixture of a hydrophilic polymeric matrix (polyvinyl alcohol and carboxymethyl cellulose) and a hydrophobic polymer (polycaprolactone) [16]. Interestingly, the nature of the drug and the drug-polymer compatibility strongly affect the release behavior of the drug from nanofiber scaffolds [14,[17][18][19].…”
Section: Introductionmentioning
confidence: 99%